Back to Research Hub
Alkermes plc
ALKS
$44.29+1.84 (+4.33%)
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally.
StreetsValue research for Alkermes plc (ALKS)
Members get the full report for Alkermes plc: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.